Testing solriamfetol for children with ADHD
Part of Mental health clinical trials.
This trial tests whether a medication called solriamfetol can safely help children with ADHD. If your child is between 6 and 12 years old and has ADHD, this study may be an option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be 6 to under 12 years old.
- Your child must have a confirmed ADHD diagnosis (using standard criteria).
- You and your child must agree to join the study and sign consent forms.
- Your child must not have any medical reason that would make the study unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine, solriamfetol, to see if it helps teenagers with ADHD. The medicine is taken as a tablet and may improve focus and reduce symptoms.
This study checks the long-term safety of the drug solriamfetol for attention-deficit/hyperactivity disorder (ADHD) in children and adolescents who have already completed an earlier study of this medication.
This study uses brain scans (EEG) to understand which children with ADHD will respond well to stimulant medications. The goal is to help doctors choose the right treatment faster by looking at brain activity patterns before starting medication.
This study compares stimulant and non-stimulant ADHD medicines in kids who have not taken ADHD medication before. It also studies how these treatments affect brain “reward” processes, which may be linked to substance-use risk.
This Phase 4 study looks at how to manage ADHD symptoms in children and teens who also have autism. It may help your child’s care team learn what treatment routines work best in real life settings.
This trial tests if iron supplements can improve restless sleep in youth with ADHD who have low iron levels. It may help if you have ADHD, sleep poorly, and your blood iron is low.
Hear when a new ADHD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.